Downregulation of N‑Myc inhibits neuroblastoma cell growth via the Wnt/β‑catenin signaling pathway

Molecular Medicine Reports
Yingge WangJingyan Liang

Abstract

Neuroblastoma, one of the most common types of cancer in childhood, is commonly treated with surgery, radiation and chemotherapy. However, prognosis and survival remain poor for children with high‑risk neuroblastoma. Therefore, the identification of novel, effective therapeutic targets is necessary. N‑Myc, a proto‑oncogene protein encoded by the v‑myc avial myelocytomatosis viral oncogene neuroblastoma derived homolog (MYCN) gene, is associated with tumorigenesis. In the present study, the effect of N‑Myc silencing on MYCN‑amplified CHP134 and BE‑2C neuroblastoma cells was evaluated, and the underlying molecular mechanism was investigated. N‑Myc was successfully knocked down using an N‑Myc‑specific small interfering RNA, the efficacy of interference efficiency confirmed by reverse transcription‑quantitative polymerase chain reaction and western blotting. Cell viability was evaluated by MTT assay and apoptosis was measured by ELISA assay. The results indicated that MYCN silencing significantly decreased cell viability and promoted apoptosis. Subsequently, the expression levels of key Wnt/β‑catenin signaling pathway proteins were detected by western blotting, and MYCN silencing was demonstrated to inhibit Wnt/β‑catenin signaling,...Continue Reading

References

Jan 1, 1986·Journal of Cellular Biochemistry·K SakselaK Nilsson
Aug 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·M SchwabJ M Bishop
Aug 15, 1997·The Biochemical Journal·G M Cohen
Sep 4, 1998·Science·T C HeK W Kinzler
Jan 23, 2002·Cell Death and Differentiation·Guy S Salvesen
Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Jul 20, 2002·Journal of Neuro-oncology·Satoshi UtsukiKiyotaka Fujii
Jan 16, 2003·Gene·Bingyu Mao, Christof Niehrs
Oct 12, 2004·Annual Review of Cell and Developmental Biology·Catriona Y Logan, Roel Nusse
Dec 2, 2006·Nature Reviews. Drug Discovery·Nick Barker, Hans Clevers
Jun 26, 2007·Lancet·John M MarisSusan L Cohn
Jul 24, 2007·Cancer Letters·Arjen KoppenLinda J Valentijn
Apr 25, 2008·Nature Reviews. Cancer·Alexandra Klaus, Walter Birchmeier
Apr 10, 2009·International Journal of Cancer. Journal International Du Cancer·Rebecca A FillmoreRajeev S Samant
Jun 10, 2009·Journal of Medical Genetics·S GhavamiM Los
Jul 7, 2009·Neurochemistry International·Gangadhara Reddy SareddyPhanithi Prakash Babu
Oct 21, 2009·Current Oncology Reports·Sabine Mueller, Katherine K Matthay
Jun 19, 2010·The New England Journal of Medicine·John M Maris
Sep 3, 2010·Clinical and Experimental Medicine·Ce LiuLianshu Ding
Feb 16, 2011·Cancer Biology & Therapy·Marco RossiAnnette Bakker
Aug 27, 2013·Biochemical and Biophysical Research Communications·Yan SongLili Cao
Oct 3, 2013·Cold Spring Harbor Perspectives in Medicine·Miller Huang, William A Weiss
Mar 6, 2015·British Journal of Cancer·J Lopez, S W G Tait
Jul 7, 2015·Scientific Reports·Brandon J MetgeRajeev S Samant

❮ Previous
Next ❯

Citations

Jul 25, 2019·Cancers·Juergen Becker, Joerg Wilting
Aug 28, 2021·International Journal of Molecular Sciences·Leila JahangiriLoukia Tsaprouni

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Adherens Junctions

An adherens junction is defined as a cell junction whose cytoplasmic face is linked to the actin cytoskeleton. They can appear as bands encircling the cell (zonula adherens) or as spots of attachment to the extracellular matrix (adhesion plaques). Adherens junctions uniquely disassemble in uterine epithelial cells to allow the blastocyst to penetrate between epithelial cells. Discover the latest research on adherens junctions here.

Cadherins and Catenins

Cadherins (named for "calcium-dependent adhesion") are a type of cell adhesion molecule (CAM) that is important in the formation of adherens junctions to bind cells with each other. Catenins are a family of proteins found in complexes with cadherin cell adhesion molecules of animal cells: alpha-catenin can bind to β-catenin and can also bind actin. β-catenin binds the cytoplasmic domain of some cadherins. Discover the latest research on cadherins and catenins here.